12:09 PM EDT, 06/03/2024 (MT Newswires) -- Gilead Sciences' ( GILD ) Kite unit said Monday that the phase 1/2 study assessing CAR T-cell therapy Tecartus in adults with relapsed or refractory B-cell acute lymphoblastic leukemia showed a median overall survival of 25.6 months and a four-year overall survival rate of 40% in all treated patients. Notably, Tecartus numerically improved...

12:03 PM EDT, 06/03/2024 (MT Newswires) -- Humana (HUM) said Monday it signed an in-network agreement with the University of Alabama at Birmingham Health System, broadening access to care for its Medicare Advantage members in Alabama. The agreement, effective earlier this year, includes access to several UAB and UAB-affiliated facilities, including UAB Hospital, UAB Hospital-Highlands and UAB Medical West, among...

Editor’s note: The headline and body of this story have been updated to correct an error in the figures for Dave Portnoy’s GameStop ( GME ) and AMC positions. Roaring Kitty (real name Keith Gill) sent GameStop Corp's ( GME ) stock into a frenzy once again Sunday night, after apparently posting a screenshot of a massive position and call-options...

Shares Agios Pharmaceuticals Inc.’s climbed after it was revealed a Phase 3 ENERGIZE-T study of mitapivat in adults with transfusion-dependent (TD) alpha-or beta-thalassemia achieved its primary endpoint of transfusion reduction response. Statistical significance was also achieved for all key secondary endpoints evaluating additional measures of reduction of transfusion burden compared to placebo. The 258-patient study met its primary endpoint of...